Cardio-HARTTM
AI Heart Diagnostic System — Fast, Accurate, At the Point of Care

Cardio-HART AI heart diagnostic system delivers hospital-grade insights in under 10 minutes. It goes beyond ECG by detecting heart failure, valve disease, and structural abnormalities at the first visit.Rule out, treat, or refer—right away.
Fewer echo referrals. Fewer repeat visits. Faster, clearer decisions—for both patients and clinicians.

Cardio-HART cardiac diagnostic system report

Early detection
and Severity

Immediate Results, 
AI-reporting

Non-invasive,
Quick

No Specialists
required

Referral decision
support

What Makes Cardio-HART Different?

More Than an ECG—Much More

Cardio-HART is a next-generation ECG device that combines novel biosignals—heart sounds (PCG) and chest wall motion (MCG)—with advanced AI to deliver diagnostic capabilities equivalent to an ECG, digital stethoscope, and echocardiogram—all in a single, ECG-like test.

Cardio – HART report includes ECG + Echo-like data.

What this delivers:

  • Detection of HF, HFpEF, valve disease, and structural heart anomalies 
  • Simpson Biplane levels of LVEF estimation and HF scoring
  • Severity information, on Echo and ECG findings
  • Structured reports, readable by any clinician—no specialist required

It’s ECG redefined—with real-time, echo-grade answers at the point of care.

94%

160%

96%

Faster Pathways, Smarter Referrals

From Bottlenecks to Breakthroughs

Use Cardio-HART
as the first test:

  • Cut echo referrals by up to 66%
  • Reduce echo waitlists and clinical backlogs
  • Enable same-day triage and improve time to treatment

This unlocks:

  • Faster diagnosis and follow-up
  • More appropriate evidence based specialist referrals
  • Echo slots reserved for truly complex cases

Aligned with NHS KPIs:

  • Earlier HF diagnosis
  • Faster treatment initiation
  • Reduced low-value diagnostics
  • Optimized outpatient pathways
  • Triggers re-allocatable cost savings

Validation Through Real-World Testing

What Happened When HCPs Faced Real Diagnostic Challenges

🧪
Study Methodology

  • Venue: 3 cardiology conferences (2024–2025)

London Diabetes & Cardiology Show, London Heart Failure Show, Seville Cardiology Congress

  • Use Case: Two inconclusive ECG cases common in GP practice
  • Data Provided:
    • ECG-only: Traces, AI Findings, Measurements
    • Cardio-HART: Full CHART Report including ECG + Echo-like data
ECG vs Cardio-HART AI heart diagnostic report comparison
Doctors reviewing ECG and Cardio-HART AI heart diagnostic reports in 2-step protocol

🔁 Two-Step Survey Protocol

Step 1: Using only ECG

Doctors had 5 minutes per case to:

  • Review the ECG, traces, findings and measurements
  • Make a diagnosis
  • Decision: refer to cardiology or treat in clinic

Step 2: Cardio-HART Review

Then, they received the Cardio-HART AI heart diagnostic report for the same case and could revise their decision.

Results

Step 1 – ECG-Only Results

~65% got both cases wrong
~5% got both cases right
~20% got 1 out of 2 right (mostly guessed)
~10% refused to answer

Diagnostic confidence was extremely low

ECG-Only Results

Step 2 – With Cardio-HART

65% initially wrong — all changed their diagnosis and decision after Cardio-HART.
20% guessed 1 right — all revised their diagnosis and decision after Cardio-HART.
5% with both right — all impressed Cardio-HART added clarity to their diagnosis and decision.
100% reached 100% diagnostic certainty after Cardio-HART.
100% saw the risk of inconclusive ECGs and the value of Cardio-HART insights.
100% agreed, Cardio-HART was a game changer
100% agreed, Cardio-HART is not a replacement for Echo, but an upgrade for ECG.

Prevention Begins at First Contact

Early Detection = Early Treatment

Cardio-HART AI heart diagnostic detects cardiac disease before symptoms escalate. Stop disease progression. Start treatment sooner.

GP-Level Power, Specialist-Grade Insight

What once required a referral to hospital for echocardiography
 can now happen in less than 10 minutes, at point of first contact.

Beyond Biomarkers

NT-proBNP is useful but underused and limited—its false positive rate is~50%1.
Cardio-HART not only confirms when NT-proBNP should be ordered, it offers on the spot physiological evidence of all three types of HF, with a Positive Predictive Value (PPV) of over 90%.

Millions Could Benefit

Earlier intervention. Fewer hospitalisations. Better patient outcomes—closer to home.

Doctor

Who it helps. Role-Based Benefits

Primary care doctor

For General Practitioners

Fits your workflow, improves diagnostic certainty

  • Triage confidently with data
  • Eliminate uncertainty in inconclusive ECGs
  • Start treatment right away

For Cardiologists

Streamlines referrals and echo prioritization

  • Better referrals, pre-triaged
  • Reduce low-yield echo demand
  • Focus on high-value imaging
Cardiologist holding 3D heart model
Cardiology patient

For Patients

Faster answers, faster care

  • One quick test, local clinic
  • Immediate results = peace of mind
  • No more long waits for hospital echo

For Commissioners (ICBs)

Earlier diagnoses saves costs, reduces wait-times and time to treatment.

  • Aligned with ICS/NHS Long Term Plan
  • Triggers re-allocattable cost savings.
  • Reduces referral burden, improves access, fosters net-zero
Commissioners - cost savings with Cardio-HART

Instant Insights: Your Top Questions

For GPs

For Cardiologists

For Patients

For Commissioners

See how Cardio-HART AI heart diagnostic
can transform your practice. Contact Us.